Poloxamer 188 copolymer stabilizes proton pump inhibitor suspensions, resolving patient compliance issues in pediatric populations.
A cohesive thin liquid bolus with specific shear viscosity and relaxation time modifies swallowing mechanics.
Pulmonary verapamil nasal spray targets calcium channels in lungs to inhibit SARS-CoV-2 replication while reducing systemic toxicity.
Non-ionic surfactants solubilize hydrophobic phytocannabinoids into stable aqueous solutions, resolving low bioavailability from poor water absorption.
A cyclodextrin-based pharmaceutical composition enhances solubility of poorly soluble substances through inclusion complex formation.
Lactobacillus casei NCU215 ferments fruit and vegetable puree to generate aromatic substances, reducing astringency while preserving nutritional ingredients.
Enzymatically degraded octenyl succinic acid modified starch provides stable emulsions with small particle sizes.
Green tea flower extract modulates PPARγ protein expression to reduce fat accumulation and adipogenesis.
Administering Nigella sativa increases VEGF and reduces von Willebrand factor to induce angiogenesis without causing cardiac hypertrophy.
A phytocannabinoid formulation combines high-concentration cannabinoids with specific lipophilic molecules to enhance bioavailability.
A fenugreek extract pharmaceutical composition interferes with viral attachment and penetration to inhibit replication.
Tangential ultrafiltration separates encapsulated salts from free salt to lower osmolality and improve palatability.
Introducing a butyl rubber gasket into the metering valve prevents oxidation and moisture ingress, keeping DP3 levels below 0.10% w/w during storage.
Segmented memantine particles coated with a cationic copolymer mask bitterness and prevent aggregation, enabling easy swallowing for dysphagia patients.
Segmented extended-release granules in single-use sachets resolve swallowing difficulties while maintaining dose accuracy.